|
Gurdane Bhutani
Managing Partner and Co-Founder
MBX Capital
|
Gurdane is a founder and Managing Partner of MBX Capital. He holds board roles at MBX partner companies Atlas Health, CareRev, Contraline, Freedom Biosciences, and Thesis.
Previously, he was the COO of FundRx, a healthcare and life sciences investment marketplace. Prior to FundRx, worked with private equity and corporate clients at Bain & Company and in public finance at Morgan Stanley. He has been an instructor on healthcare finance at the Cleveland Clinic Lerner College of Medicine and guest lecturer in the Wharton School's healthcare management program.
Gurdane earned an MPH in Epidemiology and Environmental Health Sciences from Yale University’s School of Public Health, where he was a Trowell-Harris Scholar. At Yale, he conducted research on the applications of human organoids and organ-chips in predictive toxicology. He earned his undergraduate degrees in Computer Science and Public Policy from Duke University, where he was an A.B Duke Scholar. He was a Lord Rothermere Scholar at the University of Oxford and is a Kauffman Fellow.
Previously, he was the COO of FundRx, a healthcare and life sciences investment marketplace. Prior to FundRx, worked with private equity and corporate clients at Bain & Company and in public finance at Morgan Stanley. He has been an instructor on healthcare finance at the Cleveland Clinic Lerner College of Medicine and guest lecturer in the Wharton School's healthcare management program.
Gurdane earned an MPH in Epidemiology and Environmental Health Sciences from Yale University’s School of Public Health, where he was a Trowell-Harris Scholar. At Yale, he conducted research on the applications of human organoids and organ-chips in predictive toxicology. He earned his undergraduate degrees in Computer Science and Public Policy from Duke University, where he was an A.B Duke Scholar. He was a Lord Rothermere Scholar at the University of Oxford and is a Kauffman Fellow.